|
||||||||||||||||
|
||||||||||||||||
The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. Mark Feinberg Vice President, Medical Affairs and Policy Merck Vaccines and Infectious Diseases Merck & Co., Inc. John Ferguson Vice President and Global Head Pharmacovigilance & Medical Safety Novartis Vaccines & Diagnostics David Fleming Director and Health Officer Department of Public Health Seattle/King County Rod Hausser Director Business Development and Operations BD Medical-Pharmaceutical Systems Orin Levine Executive Director, PneumoADIP Associate Professor, International Health Johns Hopkins University Adel Mahmoud Woodrow Wilson School of Public and International Affairs Department of Molecular Biology Princeton University Margaret McCluskey Senior Technical Advisor, HIV Vaccines GH/Office of HIV & AIDS U.S. Agency for International Development Melinda F. Moree Vice President, Global Health Services Kathy Neuzil Director, Influenza Vaccine Project Clinical Director, Rotavirus Vaccine Program PATH
|
|
|||||||||||||||
